Cargando…
Investigation of Anti-Tumor Effects of an MLK1 Inhibitor in Prostate and Pancreatic Cancers
SIMPLE SUMMARY: Both prostate and pancreatic cancers are ranked in the top five leading causes of cancer death in American. In prostate cancer, the mainstay of therapeutic approaches is inhibition of the androgen receptor; however, resistance occurs within two years. In pancreatic cancer, there is n...
Autores principales: | Fan, Yu-Ching, Hsu, Kai-Cheng, Lin, Tony-Eight, Zechner, Dietmar, Hsu, Sung-Po, Tsai, Yuan-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389662/ https://www.ncbi.nlm.nih.gov/pubmed/34439974 http://dx.doi.org/10.3390/biology10080742 |
Ejemplares similares
-
Cloning and Initial Functional Characterization of Mlk4α and Mlk4β
por: Kashuba, Vladimir I, et al.
Publicado: (2011) -
Anti-Inflammatory and Tau Phosphorylation–Inhibitory Effects of Eupatin
por: Chou, Ching-Hsuan, et al.
Publicado: (2020) -
TRAF2-MLK3 interaction is essential for TNF-α-induced MLK3 activation
por: Sondarva, Gautam, et al.
Publicado: (2009) -
Discovery of a novel cyclin-dependent kinase 8 inhibitor with an
oxindole core for anti-inflammatory treatment
por: Lin, Tony Eight, et al.
Publicado: (2022) -
MLK3 Signaling in Cancer Invasion
por: Rattanasinchai, Chotirat, et al.
Publicado: (2016)